(2020)
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
J Cancer Res Clin Oncol 146(3),
749-759.
Dr. Annamaria Brioli
AlumniPublications
(2019)
The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey.
Ann Hematol 98(3),
713-722.
(2017)
Safety issues and management of toxicities associated with new treatments for multiple myeloma.
Expert Rev Hematol 10(3),
193-205.
(Review)